Editas Medicine (EDIT): Wutah pendapatan triwulanan

Simbol resmi perusahaan Editas (EDIT)

Cash flow gap risks and fierce market competition are forcing Editas Medicine, Inc. (EDIT) to pivot its strategy toward licensing. Nevertheless, the brand maintains its authority due to the precision of its CRISPR platform. Quarterly revenue changes on GURU.Markets reflect its status as a scientific pioneer in genetic treatment, where 37.50 is recorded as the baseline value for the current dynamics of the business's commercial expansion.

EDIT (Editas) riwayat Tingkat wutah dodolan sajrone kuartal saka 04.07.2022 nganti 21.11.2026

Rincian analitis lan laporan data perusahaan Editas (EDIT)

- rega saham lan target rega konsensus:
Analisis umum perusahaan:editasmedicine.com (EDIT)
Produk sing diprodhuksi Editas Medicine Inc

Editas Medicine, Inc. (EDIT) focuses on the commercialization of intellectual property rights and the development of gene-editing technologies. This metric measures the percentage deviation of current quarter revenue compared to the same period last year, revealing the business's scaling pace. The current value of 37.50 allows investors to assess the effectiveness of management's updated strategy amid market volatility. GURU.Markets analysts recommend tracking changes in quarterly sales volume to verify the issuer's fundamental stability.

Pesaing Editas Medicine, Inc.

TEM - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal qiagen.com QGEN|IONS: Wutah pendapatan triwulanan|Repligen Corp - Tambahing pendapatan triwulanan|RNA (Avidity Corp) - Wutah pendapatan triwulanan|CRISPR Therapeutics Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal genedx.com (WGS)|Wutah pendapatan triwulanan ultragenyx.com (RARE)|Wutah pendapatan triwulanan BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Tingkat wutah pendapatan sajrone kuartal|twistbioscience.com - Wutah pendapatan triwulanan|10x Genomics, Inc. - Owah-owahan dodolan kuartal marang kuartal|NTLA (Intellia Corp) - Wutah dodolan triwulanan|Wutah dodolan triwulanan stoketherapeutics.com|Wutah dodolan triwulanan BLFS|Wutah dodolan triwulanan Wave Life Sciences Corp (WVE)|Wutah pendapatan triwulanan MAZE|Tingkat wutah dodolan sajrone kuartal Sionna Therapeutics Inc|Wutah pendapatan kuartal marang kuartal Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Tingkat wutah pendapatan sajrone kuartal|QURE - Wutah pendapatan kuartal marang kuartal|MeiraGTx Holdings (MGTX) - Wutah dodolan triwulanan|Regenxbio (RGNX) - Wutah pendapatan kuartal marang kuartal|SLDB - Tingkat wutah dodolan sajrone kuartal|OCGN (Ocugen Inc) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal PACB|Wutah pendapatan kuartal marang kuartal Benitec (BNTC)|Design Therapeutics Inc - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Rocket Pharma RCKT|Wutah pendapatan triwulanan 4DMT FDMT|LXEO - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Korro Bio Inc.|SLN: Wutah pendapatan triwulanan|ProQR - Tambahing pendapatan triwulanan|CDXS (Codexis) - Wutah pendapatan triwulanan|Sangamo (SGMO) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan NAUT|Wutah dodolan triwulanan Metagenomi, Inc. MGX|Wutah pendapatan kuartal marang kuartal Precision BioSciences DTIL|Tambahing pendapatan triwulanan GBIO|BOLD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Wutah pendapatan kuartal marang kuartal|RXi Pharmaceuticals - Tambahing pendapatan triwulanan|MBIO (Mustang Bio) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal RNAZ (transcodetherapeutics.com)|Wutah pendapatan kuartal marang kuartal Bionano (BNGO)|Applied DNA Sciences - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Tingkat wutah pendapatan sajrone kuartal|omegatherapeutics.com - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Singular Genomics Systems Inc (OMIC)|RGLS: Wutah pendapatan triwulanan|Syros Pharmaceuticals, Inc (SYRS) - Wutah pendapatan triwulanan|TBIO (telesisbio.com) - Wutah pendapatan triwulanan|TCON: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Unity Biotechnology, Inc (UBX)